Olivier Meilhac Selected Research

CSL-111

1/2020

Reconstituted High-density Lipoprotein Therapy Improves Survival in Mouse Models of Sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Meilhac Research Topics

Disease

25	Thrombosis (Thrombus) 04/2016 - 06/2003
23	Atherosclerosis 12/2021 - 11/2002
18	Atherosclerotic Plaque (Atheroma) 12/2021 - 06/2003
14	Inflammation (Inflammations) 01/2022 - 03/2011
14	Abdominal Aortic Aneurysm 12/2016 - 06/2004
13	Stroke (Strokes) 05/2022 - 07/2010
12	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 10/2006
11	Hyperglycemia 04/2022 - 01/2017
9	Infarction (Infarctions) 05/2022 - 11/2005
9	Ischemic Stroke 05/2022 - 04/2013
9	Sepsis (Septicemia) 01/2021 - 12/2017
9	Aneurysm (Aneurysms) 02/2016 - 06/2004
8	COVID-19 04/2022 - 01/2020
8	Rupture 09/2021 - 03/2007
7	Type 2 Diabetes Mellitus (MODY) 01/2019 - 10/2012
6	Hemorrhage 06/2016 - 12/2007
5	Insulin Resistance 04/2022 - 01/2017
5	Obesity 04/2022 - 01/2013
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2012
5	Periodontitis 01/2022 - 09/2012
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2022 - 10/2019
4	Hemolysis 10/2020 - 09/2012
4	Myocardial Infarction 01/2018 - 10/2004
4	Ischemia 01/2018 - 04/2011
4	Acute Coronary Syndrome 11/2014 - 07/2005
4	Cicatrix (Scar) 12/2011 - 05/2002
3	Brain Infarction 04/2022 - 04/2011
3	Coronary Disease (Coronary Heart Disease) 12/2021 - 04/2014
3	Fibrosis (Cirrhosis) 03/2021 - 12/2011
3	Periodontal Diseases (Periodontal Disease) 06/2016 - 04/2011
2	Dyslipidemias (Dyslipidemia) 04/2022 - 07/2005
2	Brain Ischemia (Cerebral Ischemia) 10/2021 - 10/2014
2	Diabetes Mellitus 01/2021 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020 - 07/2017
2	Vascular Calcification 10/2020 - 11/2018
2	Neoplasms (Cancer) 01/2020 - 10/2004
2	Cerebral Infarction 01/2020 - 10/2016
2	Pneumonia (Pneumonitis) 01/2020 - 01/2020
2	Reperfusion Injury 01/2018 - 12/2011
2	Vascular Diseases (Vascular Disease) 01/2017 - 07/2005

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 10/2018 - 07/2005
15	HDL LipoproteinsIBA 03/2022 - 07/2010
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2003
11	Lipoproteins (Lipoprotein)IBA 01/2022 - 11/2002
11	LipidsIBA 12/2021 - 10/2006
11	Phenobarbital (Luminal)FDA Link 02/2016 - 06/2004
11	Peptide Hydrolases (Proteases)FDA Link 05/2013 - 05/2002
9	Biological ProductsIBA 07/2017 - 06/2006
9	Pancreatic Elastase (Elastase)IBA 02/2016 - 05/2002
8	AntioxidantsIBA 04/2022 - 11/2013
7	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 04/2013
7	HDL CholesterolIBA 03/2022 - 06/2015
6	PolyphenolsIBA 04/2022 - 01/2017
6	Hemoglobins (Hemoglobin)IBA 10/2021 - 12/2007
6	CytokinesIBA 09/2021 - 01/2012
6	Advanced Glycation End ProductsIBA 01/2021 - 01/2017
6	Matrix Metalloproteinases (MMPs)IBA 11/2018 - 05/2002
5	CholesterolIBA 12/2021 - 08/2012
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 09/2012
5	Conditioned Culture MediaIBA 08/2013 - 12/2007
4	Neuroprotective AgentsIBA 05/2022 - 07/2010
4	Peptides (Polypeptides)IBA 01/2022 - 02/2010
4	oxidized low density lipoproteinIBA 12/2021 - 10/2014
4	Interleukin-6 (Interleukin 6)IBA 04/2021 - 07/2005
3	caffeic acidIBA 04/2022 - 01/2020
3	Insulin (Novolin)FDA Link 01/2022 - 01/2019
3	Lipoprotein(a)IBA 01/2022 - 01/2018
3	ProteomeIBA 01/2021 - 09/2012
3	LDL CholesterolIBA 01/2021 - 10/2014
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2020 - 05/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2019 - 04/2007
3	SubtilisinIBA 01/2018 - 08/2012
3	omega-Chloroacetophenone (Mace)IBA 01/2018 - 05/2014
3	Fibrinolysin FDA Link 02/2012 - 05/2002
3	HSP27 Heat-Shock ProteinsIBA 01/2008 - 10/2004
2	AdiponectinIBA 05/2022 - 10/2019
2	EpitopesIBA 04/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 04/2022 - 01/2022
2	BNT162 VaccineIBA 04/2022 - 01/2022
2	VaccinesIBA 04/2022 - 01/2022
2	LDL Lipoproteins (beta Lipoproteins)IBA 12/2021 - 09/2012
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2021 - 02/2012
2	Blood Glucose (Blood Sugar)IBA 10/2021 - 01/2020
2	Immunoglobulin G (IgG)IBA 10/2021 - 11/2014
2	Peroxidase (Myeloperoxidase)IBA 10/2021 - 12/2007
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 06/2015
2	Sirolimus (Rapamycin)FDA Link 12/2020 - 01/2020
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2020 - 07/2010
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2019
2	Apolipoproteins E (ApoE)IBA 05/2019 - 11/2018
2	LigandsIBA 05/2019 - 04/2014
2	CatalaseIBA 01/2019 - 12/2011
2	EnzymesIBA 01/2019 - 06/2006
2	ischemia-modified albuminIBA 01/2018 - 01/2017

Therapy/Procedure

15	Therapeutics 01/2022 - 10/2006
3	Intraperitoneal Injections 10/2021 - 01/2017
3	Ligation 01/2020 - 11/2005
3	Lasers (Laser) 04/2011 - 07/2008
2	Intravenous Injections 01/2020 - 03/2013
2	Carotid Endarterectomy 11/2018 - 01/2012